Feasibility of machine learning-based modeling and prediction using multiple centers data to assess intrahepatic cholangiocarcinoma outcomes

References

• Mejia JC, Pasko J. Primary liver cancers: intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Surg Clin North Am. 2020;100(3):535–549.
   PubMed Web of Science ®Google Scholar
• Gruttadauria S, Barbera F, Pagano D, et al. Liver transplantation for unresectable intrahepatic cholangiocarcinoma: the role of sequencing genetic profiling. Cancers. 2021;13(23):6049.
   PubMed Web of Science ®Google Scholar
• Tashiro S, Tsuji T, Miyake H, et al. Strategy for improving the prognosis of patients with intrahepatic cholangiocarcinoma by surgical treatment: considerations based on experience and a literature review. J. Med. Invest. 2021;68(1.2):15–21. (
   PubMed Web of Science ®Google Scholar
• Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer. Lancet. 2021;397(10272):428–444.
   PubMed Web of Science ®Google Scholar
• Kodali S, Shetty A, Shekhar S, et al. Management of intrahepatic cholangiocarcinoma. J Clin Med. 2021;10(11):2368.
   PubMed Web of Science ®Google Scholar
• Kelley RK, Bridgewater J, Gores GJ, et al. Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72(2):353–363.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Dataset; [cited 2021 Jun]. Available from: https://seer.cancer.gov/data-software/.
   Google Scholar
• Lee AJ, Chun YS. Intrahepatic cholangiocarcinoma: the AJCC/UICC 8th edition updates. Chin Clin Oncol. 2018;7(5):52.
   PubMed Web of Science ®Google Scholar
• Pölsterl S. Scikit-survival: a library for time-to-event analysis built on top of scikit-learn. J Mach Learn Res. 2020;21:1–6.
   PubMed Web of Science ®Google Scholar
• Ishwaran H, Kogalur UB, Blackstone EH, et al. Random survival forests. Ann Appl Stat. 2008;2(3):841–860.
   Web of Science ®Google Scholar
• Breiman L. Random forests. Mach Learn. 2001;45(1):5–32.
   Web of Science ®Google Scholar
• Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Conference on Neural Information Processing Systems. 2017; December: 4768–4777.
   Google Scholar
• Lundberg SM, Nair B, Vavilala MS, et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat Biomed Eng. 2018;2(10):749–760.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Yamauchi N, Ushiku T, et al. Tumor budding in intrahepatic cholangiocarcinoma: a predictor of postsurgery outcomes. Am J Surg Pathol. 2019;43(9):1180–1190.
   PubMed Web of Science ®Google Scholar
• Wei T, Zhang XF, He J, et al. Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study. Br J Surg. 2022;109(7):610–616.
   PubMed Web of Science ®Google Scholar
• Zhou SN, Lu SS, Ju DW, et al. A new prognostic model covering all stages of intrahepatic cholangiocarcinoma. J Clin Transl Hepatol. 2022;10(2):254–262.
   PubMed Web of Science ®Google Scholar
• Yeh YC, Lei HJ, Chen MH, et al. C-Reactive protein (CRP) is a promising diagnostic immunohistochemical marker for intrahepatic cholangiocarcinoma and is associated with better prognosis. Am J Surg Pathol. 2017;41(12):1630–1641.
   PubMed Web of Science ®Google Scholar
• Zheng BH, Yang LX, Sun QM, et al. A new preoperative prognostic system combining CRP and CA199 for patients with intrahepatic cholangiocarcinoma. Clin Transl Gastroenterol. 2017;8(10):e118.
   PubMedGoogle Scholar
• Moro A, Mehta R, Sahara K, et al. The impact of preoperative CA19-9 and CEA on outcomes of patients with intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2020;27(8):2888–2901.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zheng Y, Zhao H, et al. The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection. Ann Transl Med. 2020;8(5):192.
   PubMed Web of Science ®Google Scholar
• Lee JW, Lee JH, Park Y, et al. Prognostic impact of perioperative CA19-9 levels in patients with resected perihilar cholangiocarcinoma. J Clin Med. 2021;10(7):1345.
   PubMed Web of Science ®Google Scholar
• Rafique R, Islam SMR, Kazi JU. Machine learning in the prediction of cancer therapy. Comput Struct Biotechnol J. 2021;19:4003–4017.
   PubMed Web of Science ®Google Scholar
• Kourou K, Exarchos TP, Exarchos KP, et al. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8–17.
   PubMed Web of Science ®Google Scholar
• Mosele F, Remon J, Mateo J, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group. Ann Oncol. 2020;31(11):1491–1505.
   PubMed Web of Science ®Google Scholar
• Miao R, Chen HH, Dang Q, et al. Beyond the limitation of targeted therapy: improve the application of targeted drugs combining genomic data with machine learning. Pharmacol Res. 2020;159:104932.
   PubMed Web of Science ®Google Scholar
• Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920–1930.
   PubMed Web of Science ®Google Scholar
• Kennedy L, Zhang W, Ekser B, et al. Current advances in basic and translational research of cholangiocarcinoma. Cancers. 2021;13(13):3307.
   PubMed Web of Science ®Google Scholar
• Rompianesi G, Di Martino M, Gordon-Weeks A, et al. Liquid biopsy in cholangiocarcinoma: current status and future perspectives. World J Gastrointest Oncol. 2021;13(5):332–350.
   PubMed Web of Science ®Google Scholar